Scientist studies tissue culture in lab
Media Coverage

Contract Pharma Newsmakers: Charles River

Contract Pharma

Early drug development is growing more imperative as drug developers want to pursue only those candidates that will lead to greater safety and efficacy profiles down the road. Also, with the therapeutic research areas of oncology and immunology growing rapidly and discovery research in these areas becoming increasingly complex, specialized capabilities are needed to develop today’s next-gen therapeutics.

Join Greg Beattie and Andy Vick as they discuss our recent acquisitions and key expansions to our biologic testing services with Contract Pharma.

Read the full article